Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

China Pharma Holdings, Inc. CPHI

Set alert

Price alert · CPHI

All alert types
0.62 USD -0.03 -3.86%

At close · Oct 30

0.61 -0.01 -1.87%

After hours · Oct 30, 7:58 PM ET

Bid
0.60 × 4,400
Ask
0.64 × 1,000
0.6065 Day range 0.6748
0.52 52-week range 8.10
YTD
-48.36%
1 year
-63.88%
Open
0.65
Prev close
0.65
Mkt cap
26.88M
Vol
184.28K
Avg vol
1.90M
EPS
-0.42
P/E
0.00
Div yield
0.00%
More statistics
Low
0.6065
High
0.6748
Forward P/E
0.00
Beta
0.71
Short ratio
0.22
Inst. own
0.21%
Dividend
0.00
Ex-div date
50-d avg
0.214
200-d avg
0.2588
1y target
0.00

3M chart

Chart tools
Interval
1m5m15m30m

Signals (10)
NameDateAgo
MACD: Sell SignalOct 22, 20261 week ago
SMA: BearishOct 13, 20262 weeks ago
SMA: BearishOct 9, 20263 weeks ago
SMA: BullishOct 8, 20263 weeks ago
SMA: BullishOct 7, 20263 weeks ago
MACD: Buy SignalSep 23, 20261 month ago
SMA: BearishAug 17, 20262 months ago
SMA: BearishAug 6, 20262 months ago
SMA: BullishAug 5, 20262 months ago
SMA: BearishJul 31, 20263 months ago

Financial health

Altman Z-Score

-0.06 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 5

Valuation

P/E -1.6×
FY 2016: -61.6×FY 2017: -19.9×FY 2018: -52.1×FY 2019: -24.6×FY 2020: -310×FY 2021: -284×FY 2022: -24.7×FY 2023: -20.9×FY 2024: -8.6×FY 2025: -1.6×
FY 2016 5y median -20.9× FY 2025
P/S 1.3×
FY 2016: 38.5×FY 2017: 30.7×FY 2018: 48.1×FY 2019: 50.0×FY 2020: 94.6×FY 2021: 115×FY 2022: 31.1×FY 2023: 9.1×FY 2024: 9.0×FY 2025: 1.3×
FY 2016 5y median 9.1× FY 2025
P/B 0.2×
FY 2016: 10.2×FY 2017: 9.4×FY 2018: 19.7×FY 2019: 59.1×FY 2020: 128×FY 2021: 185×FY 2022: 58.8×FY 2023: 8.6×FY 2024: 5.3×FY 2025: 0.2×
FY 2016 5y median 8.6× FY 2025
P/FCF 472×
FY 2016: 222×FY 2017: 575×FY 2018: 492×FY 2019: 1156×FY 2020: -1130×FY 2021: -1618×FY 2022: -311×FY 2023: -90.2×FY 2024: -53.7×FY 2025: 472×
FY 2016 5y median -90.2× FY 2025
EV/EBITDA -5.8×
FY 2016: -123×FY 2017: -26.9×FY 2018: -84.0×FY 2019: -31.6×FY 2020: 9683×FY 2021: 4865×FY 2022: -309×FY 2023: 7983×FY 2024: -22.2×FY 2025: -5.8×
FY 2016 5y median -5.8× FY 2025
EV/Sales 2.1×
FY 2016: 39.1×FY 2017: 31.3×FY 2018: 48.7×FY 2019: 50.5×FY 2020: 95.2×FY 2021: 116×FY 2022: 32.0×FY 2023: 9.6×FY 2024: 9.6×FY 2025: 2.1×
FY 2016 5y median 9.6× FY 2025
FCF Yield 0.2%
FY 2016: 0.5%FY 2017: 0.2%FY 2018: 0.2%FY 2019: 0.1%FY 2020: -0.1%FY 2021: -0.1%FY 2022: -0.3%FY 2023: -1.1%FY 2024: -1.9%FY 2025: 0.2%
FY 2016 5y median -0.3% FY 2025

Profitability

Gross Margin -3.2%
FY 2016: 20.7%FY 2017: 18.7%FY 2018: 16.0%FY 2019: 13.6%FY 2020: 18.0%FY 2021: 3.6%FY 2022: -6.1%FY 2023: -4.0%FY 2024: -43.8%FY 2025: -3.2%
FY 2016 5y median -4.0% FY 2025
Operating Margin -74.5%
FY 2016: -26.9%FY 2017: -34.0%FY 2018: -32.2%FY 2019: -31.0%FY 2020: -23.7%FY 2021: -29.7%FY 2022: -43.8%FY 2023: -39.2%FY 2024: -101.3%FY 2025: -74.5%
FY 2016 5y median -43.8% FY 2025
Net Margin -76.9%
FY 2016: -59.0%FY 2017: -145.9%FY 2018: -87.2%FY 2019: -189.5%FY 2020: -26.4%FY 2021: -35.3%FY 2022: -49.0%FY 2023: -43.9%FY 2024: -104.6%FY 2025: -76.9%
FY 2016 5y median -49.0% FY 2025
ROE -14.0%
FY 2016: -15.6%FY 2017: -44.8%FY 2018: -35.6%FY 2019: -224.1%FY 2020: -35.8%FY 2021: -56.5%FY 2022: -92.6%FY 2023: -41.3%FY 2024: -61.1%FY 2025: -14.0%
FY 2016 5y median -56.5% FY 2025
ROIC -11.3%
FY 2016: -5.9%FY 2017: -8.4%FY 2018: -10.1%FY 2019: -20.4%FY 2020: -15.9%FY 2021: -14.8%FY 2022: -25.7%FY 2023: -21.4%FY 2024: -38.0%FY 2025: -11.3%
FY 2016 5y median -21.4% FY 2025
ROA -10.3%
FY 2016: -11.7%FY 2017: -32.2%FY 2018: -23.7%FY 2019: -93.1%FY 2020: -13.6%FY 2021: -15.0%FY 2022: -22.3%FY 2023: -18.7%FY 2024: -31.8%FY 2025: -10.3%
FY 2016 5y median -18.7% FY 2025

Growth (YoY)

Revenue -8.5%
FY 2016: -23.5%FY 2017: -15.1%FY 2018: -6.7%FY 2019: -11.4%FY 2020: -0.5%FY 2021: -11.3%FY 2022: -15.9%FY 2023: -13.5%FY 2024: -35.4%FY 2025: -8.5%
FY 2016 FY 2025
Operating Income 32.7%
FY 2016: 70.5%FY 2017: -7.2%FY 2018: 11.7%FY 2019: 14.6%FY 2020: 23.9%FY 2021: -10.9%FY 2022: -24.1%FY 2023: 22.5%FY 2024: -66.8%FY 2025: 32.7%
FY 2016 FY 2025
EPS (diluted) -174.1%
FY 2016: 40.4%FY 2017: -109.5%FY 2018: 44.1%FY 2019: -95.1%FY 2020: 85.1%FY 2021: -18.1%FY 2022: -128.2%FY 2023: 85.1%FY 2024: 6.9%FY 2025: -174.1%
FY 2016 FY 2025
Free Cash Flow 101.5%
FY 2016: 162.2%FY 2017: -73.9%FY 2018: 71.1%FY 2019: -60.8%FY 2020: -292.6%FY 2021: 24.4%FY 2022: -18.0%FY 2023: 12.4%FY 2024: -6.6%FY 2025: 101.5%
FY 2016 FY 2025

Financial Health

Current Ratio 0.3×
FY 2016: 1.7×FY 2017: 1.3×FY 2018: 0.9×FY 2019: 0.6×FY 2020: 0.5×FY 2021: 0.9×FY 2022: 0.5×FY 2023: 0.9×FY 2024: 0.7×FY 2025: 0.3×
FY 2016 5y median 0.7× FY 2025
Quick Ratio 0.1×
FY 2016: 1.0×FY 2017: 0.6×FY 2018: 0.4×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.5×FY 2022: 0.2×FY 2023: 0.3×FY 2024: 0.2×FY 2025: 0.1×
FY 2016 5y median 0.2× FY 2025
Debt / Equity 0.2×
FY 2016: 0.2×FY 2017: 0.2×FY 2018: 0.3×FY 2019: 0.7×FY 2020: 0.9×FY 2021: 2.1×FY 2022: 2.0×FY 2023: 0.6×FY 2024: 0.5×FY 2025: 0.2×
FY 2016 5y median 0.6× FY 2025
Net Debt / EBITDA -2.4×
FY 2016: -1.7×FY 2017: -0.5×FY 2018: -0.9×FY 2019: -0.3×FY 2020: 60.6×FY 2021: 33.1×FY 2022: -8.0×FY 2023: 381×FY 2024: -1.5×FY 2025: -2.4×
FY 2016 5y median -1.5× FY 2025
Interest Coverage -30.3×
FY 2016: -4.9×FY 2017: -8.3×FY 2018: -8.8×FY 2019: -10.5×FY 2020: -8.8×FY 2021: -5.3×FY 2022: -8.2×FY 2023: -8.2×FY 2024: -29.8×FY 2025: -30.3×
FY 2016 5y median -8.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31